Alcon (ALC) stock
Last close $74.50 on 2026-11-19 (-1.01%) · Sector: Healthcare
Alcon is a medical company based in Geneva, Switzerland, that focuses on eye care, making products such as surgical equipment, contact lenses, and eye drops. It earns money by selling these products to eye doctors, hospitals, and patients around the world.
Alcon has been a solid business, with revenue growing 10.5% over the past year and a very strong balance sheet with no long-term debt. The stock has not kept pace with the broader market, returning -0.7% over the past year while the S&P 500 gained 9.7%. The stock is trading 8.9% above its 50-day average and 4.1% above its 200-day average, though it sits 15.0% below its 52-week high. No insider sales or purchases and no Congress trades were reported in the last 90 days, and no stock moves after earnings releases are available for this stock.
Key numbers
- Revenue (last 12 months): $7.18B
- Revenue growth: +10.5%
- Gross margin: 76.7%
- Operating margin: 34.4%
- P/E: 10.2
- Debt to equity: 0.00
- Current ratio: 3.39
Quality score
Overall 69/100 · growth 38 · profitability 61 · financial health 87 · value 90
Performance and risk
1-year return -0.7% vs S&P 500 +9.7% · volatility 29.1% (S&P 500 13.8%) · largest drop -28.9% · beta 0.36
Insider trades (12 months)
Bought $0.0M · sold $0.0M
ALC stock research · ALC options calculator · Stocks to buy, hold or sell today
StrikeWright provides AI signals only, not financial advice.